Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.42 +0.04 (+1.18%)
As of: Sep 30, 2026 · 10:23 AM EDT

Insight Molecular Diagnostics (IMDX) EBIT Margin (2020 - 2026)

Updated

Insight Molecular Diagnostics' EBIT Margin came in at -4770.71% for Q2 2026, down 2870.71 percentage points from -1900.00% a year earlier but up 9019.91 percentage points from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) EBIT Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Insight Molecular Diagnostics reported EBIT Margin of -3011.86%, down 1513.55 percentage points year-over-year; for FY2025, it was -1260.76%, up 1984.37 percentage points from FY2024.

  • EBIT Margin carries a five-year change of +1182.57 percentage points (FY2020 to FY2025).
  • Going back by year, EBIT Margin was -3245.14% in FY2024 (-1572.75 pp), -1672.39% in FY2023 (+206.21 pp), -1878.60% in FY2022 (+565.67 pp) and -2444.27% in FY2021 (-0.93 pp).
  • The five-year range for quarterly EBIT Margin is -13790.63% (Q1 2026) to 1969.70% (Q1 2023).
  • Year-over-year, EBIT Margin increased in five of the last eight quarters, with an average year-over-year change of -1059.77 percentage points.
  • The fastest year-over-year change in EBIT Margin over five years came in Q3 2025 (a gain of 7502.94 percentage points), and the weakest in Q1 2026 (a drop of 13472.62 percentage points).
  • Business Quant data shows IMDX's EBIT Margin at -13790.63% (Q1 2026), -2057.51% (Q4 2025) and -4249.23% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 13.44%
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 33.60%
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 18.08%
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 25.18%
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 21.65%
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 13.31%
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 29.48%
10 Insight Molecular Diagnostics 103.74 Mn 27.46 Mn 157,000.00 -4,770.71%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,770.71%
Mar 31, 2026 -13,790.63%
Dec 31, 2025 -2,057.51%
Sep 30, 2025 -4,249.23%
Jun 30, 2025 -1,900.00%
Mar 31, 2025 -318.01%
Dec 31, 2024 -2,262.92%
Sep 30, 2024 -11,752.17%
Jun 30, 2024 -4,453.85%
Mar 31, 2024 -5,265.34%
Dec 31, 2023 -5,152.55%
Sep 30, 2023 -1,518.18%
Jun 30, 2023 -1,791.36%
Mar 31, 2023 1,969.70%
Dec 31, 2022 -4,251.09%
Sep 30, 2022 -2,546.27%
Jun 30, 2022 -686.08%
Mar 31, 2022 -793.95%
Dec 31, 2021 -994.15%
Sep 30, 2021 -1,382.52%
API Access

Insight Molecular Diagnostics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMDX&period=max&api_key=YOUR_API_KEY